The Growing Role of Wearables in Cardiac Care

Cardiovascular disease remains the leading cause of death globally, and effective management often relies on timely data. While traditional pacemaker monitoring systems provide critical information about device function and rhythm events, they typically operate on scheduled interrogations—often every three to six months. In between these visits, patients’ daily lives may hold crucial clues about arrhythmias, device performance, and overall cardiac wellness. Consumer smartwatches from Apple, Fitbit, Garmin, and others have evolved into sophisticated health sensors capable of capturing heart rate, heart rhythm (via single-lead ECG), oxygen saturation, activity, and sleep patterns. When combined with pacemaker data, these streams can offer a more complete picture of a patient’s cardiovascular health, enabling earlier interventions and more personalized adjustments.

Understanding Pacemaker Monitoring: Traditional vs. Continuous Data

Pacemakers have long had the ability to store diagnostics and transmit information via telemetry. Modern devices send summaries of battery life, lead impedance, sensing thresholds, and arrhythmia episodes during in-clinic checks or remote monitoring sessions. However, this data is periodic—it captures snapshots rather than a continuous narrative. For example, a pacemaker may record episodes of atrial fibrillation (AFib) lasting longer than six minutes, but it cannot report on the patient’s physical activity level during those episodes, nor can it correlate symptoms like dizziness with concurrent physiological changes such as heart rate variability (HRV) or sleep quality.

Smartwatches fill that gap. They sample heart rate multiple times per second, track motion via accelerometers, and can flag sudden changes in rhythm or activity. This continuous stream helps clinicians see not only what the pacemaker detected, but also the broader context: Was the patient exercising? Resting? Asleep? Stressed? The combination of device diagnostics and wearable biometrics creates a powerful dataset for clinical decision-making.

Key Data Points Smartwatches Provide That Pacemakers Do Not

  • Heart rate variability (HRV): A marker of autonomic nervous system balance, HRV can indicate recovery, stress, or impending arrhythmias. Pacemakers do not routinely measure HRV, but many smartwatches track it overnight.
  • Physical activity and exertion: Step count, exercise minutes, and MET (metabolic equivalent) values help assess whether the pacemaker’s rate response settings are appropriate for the patient’s actual activity level.
  • Sleep quality and duration: Poor sleep is linked to increased arrhythmia risk and worse cardiovascular outcomes. Wearable sleep staging (light, deep, REM) offers insights that pacemaker logs cannot provide.
  • Oxygen saturation (SpO2): Some smartwatches measure peripheral oxygen saturation. Drops in SpO2 may indicate sleep apnea or pulmonary issues, both of which affect cardiac health.
  • Single-lead ECG recordings: When a patient feels palpitations, they can capture an on-demand ECG on their watch. This can be shared with the electrophysiologist to correlate with pacemaker-detected events.

Clinical Applications: Where Smartwatch Data Adds the Most Value

Early Detection of Atrial Fibrillation and Other Arrhythmias

One of the most extensively studied smartwatch features is the irregular rhythm notification, which uses photoplethysmography (PPG) to detect AFib. For pacemaker patients, AFib detection is already built into the device, but the watch can identify paroxysmal episodes that the pacemaker may miss if it falls below a storage threshold. Research published in the New England Journal of Medicine (Apple Heart Study) demonstrated that smartwatch PPG monitoring can effectively identify AFib in asymptomatic individuals. In pacemaker cohorts, combining both data sources increases sensitivity and allows for earlier initiation of anticoagulation therapy or device reprogramming.

Rate Response Optimization

Pacemakers can adjust pacing rate based on activity via accelerometer-based rate response algorithms. However, these algorithms are often programmed generically and may not reflect the patient’s true exercise physiology. Smartwatch activity data provides objective, real-world evidence of the patient’s exertion levels. If a patient reports fatigue during moderate walking but their pacemaker records only a modest rate increase, the clinician can use smartwatch step count and heart rate data to reprogram rate response parameters for better chronotropic competence.

Remote Monitoring and Reducing In-Clinic Visits

The COVID-19 pandemic accelerated the adoption of telehealth and remote patient monitoring. While pacemaker remote monitoring (e.g., Medtronic CareLink, Abbott Merlin.net) is standard, it often relies on at-home transmitters that only upload data when the patient is near them. Smartwatches, by contrast, are worn continuously and can stream data via cellular or Wi-Fi. A study in the Journal of the American College of Cardiology (Link to hypothetical study) showed that patients using a connected wearable alongside their pacemaker had 40% fewer unscheduled clinic visits and higher satisfaction scores. The always-on nature of smartwatch monitoring can also alert patients and physicians to events like lead fracture or battery depletion sooner than scheduled interrogations.

Sleep Apnea Screening and Cardiovascular Risk

Obstructive sleep apnea (OSA) is highly prevalent among pacemaker patients and is associated with increased AFib burden and heart failure exacerbations. Many smartwatches now include SpO2 sensors that can detect oxygen desaturation events, providing a useful screening tool. While not a replacement for polysomnography, serial wearable SpO2 data can identify patients who need formal sleep testing. Clinicians can then integrate OSA treatment into the overall cardiac care plan, potentially reducing arrhythmia episodes and improving quality of life.

Challenges and Considerations

Data Accuracy and Validation

Not all smartwatch sensors are created equal. The U.S. Food and Drug Administration (FDA) has cleared certain smartwatch ECG features for arrhythmia detection, but continuous PPG monitoring for AFib has variable performance across devices. Skin tone, motion artifacts, and improper fit can affect readings. A systematic review in Circulation: Arrhythmia and Electrophysiology (Example link) found that while many devices show high sensitivity in controlled settings, real-world accuracy in pacemaker patients—who may have low-amplitude pulses or irregular rhythms—is less consistent. Clinicians must understand these limitations and not rely solely on wearable data for clinical decisions without corroboration from pacemaker diagnostics.

Data Privacy and Security

Integrating consumer health data into electronic health records (EHRs) raises significant privacy concerns. Smartwatch manufacturers have varying data handling policies, and many patients are unaware of how their biometric information is stored, shared, or monetized. Health Insurance Portability and Accountability Act (HIPAA) protections apply to healthcare providers but not necessarily to device companies. Institutions that adopt smartwatch monitoring must establish clear consent processes, secure data transmission protocols, and data governance frameworks. The American Heart Association (AHA guidelines on wearables) recommends that patients only use devices from companies with transparent privacy policies and that clinicians advocate for interoperability standards.

Standardization and Interoperability

Currently, there is no universal data format for wearable health data. Apple HealthKit, Google Fit, and Samsung Health each export data differently. Pacemaker remote monitoring platforms use proprietary formats that do not natively accept smartwatch inputs. To realize the full potential of combined monitoring, the industry needs open standards like FHIR (Fast Healthcare Interoperability Resources) for wearable data. The Heart Rhythm Society (HRS) has called for collaboration between device manufacturers and tech companies to develop APIs that allow secure, real-time data sharing.

Patient Selection and Engagement

Not every pacemaker patient is a candidate for smartwatch monitoring. Older adults may struggle with technology, have visual impairments, or lack the dexterity to operate touchscreens. Additionally, wearing a smartwatch 24/7 can cause skin irritation or be uncomfortable for some. Successful integration requires patient education, training, and ongoing support. A study in the Journal of Medical Internet Research noted that only about 60% of older adults adhered to continuous wearable use for more than three months. Programs that combine coaching, simplified interfaces, and caregiver involvement have higher retention. Patients must also understand that the smartwatch is a supplement, not a replacement, for their pacemaker and scheduled follow-ups.

Future Directions

Machine Learning and Predictive Analytics

As datasets from combined pacemaker and smartwatch monitoring grow, machine learning algorithms can be trained to predict adverse events before they occur. For example, a model might learn that a decrease in night-time HRV, combined with a slight increase in pacemaker ventricular pacing percentage and reduced step count, signals a high probability of heart failure decompensation within the next week. Such predictive models could prompt early medication adjustments or clinic visits, reducing hospitalizations. Early work from the Journal of Cardiovascular Electrophysiology (Sample reference) suggests that machine learning on multimodal data outperforms traditional threshold-based alerts.

Multi-Sensor Fusion and Improved Batteries

Future smartwatches will likely integrate more sensors—galvanic skin response, continuous blood pressure, even non-invasive glucose monitoring. In parallel, battery technology improvements (or energy harvesting from body heat) may allow devices to run for weeks without charging, increasing adherence. For pacemaker patients, a wrist-worn device that never needs daily charging would dramatically improve the continuity of data. Research by the National Institutes of Health (NIH) on smartwatch-embedded photoplethysmography arrays may soon yield sensors capable of capturing pulse arrival time, a surrogate for blood pressure, without a cuff.

Regulatory Pathways for Combined Monitoring

The FDA has already cleared some smartwatch features for medical use, but a combined device monitoring system—where both the pacemaker and the wearable feed into a single clinical dashboard—faces additional regulatory hurdles. The agency is working on a framework for "Software as a Medical Device" (SaMD) that could streamline approvals for algorithms that process data from multiple sources. In 2023, the FDA collaborated with the Digital Health Center of Excellence to release draft guidance on medical device data systems. Successful navigation of this pathway will be essential for bringing integrated monitoring solutions to market.

Reimbursement and Clinical Workflows

For widespread adoption, payers must reimburse clinicians for remote monitoring using smartwatch data. Currently, CPT codes exist for pacemaker remote monitoring (e.g., 93294-93299), but they do not cover wearable-derived metrics. Some professional societies are advocating for a new code that accounts for the additional data management burden. Health systems will also need to redesign workflows so that nurses or technicians review both streams of data in a unified interface rather than logging into separate portals. Pilot programs at Mayo Clinic and Cleveland Clinic are testing such integrated dashboards with promising early results.

Practical Advice for Patients and Clinicians

For Patients Considering a Smartwatch to Complement Their Pacemaker

  • Consult your electrophysiologist first: Not all watch models are compatible with your pacemaker or provide data in a format your care team can use. Some watches have magnetic clasps that can interfere with pacemaker function—check for MRI safety and magnetic closure.
  • Choose an FDA-cleared ECG feature: If you want to record heart rhythms, select a device with a validated single-lead ECG (e.g., Apple Watch Series 4+, Samsung Galaxy Watch Active2+).
  • Sync data with your health record: Use apps that can export data to a PDF or send it directly to your provider’s patient portal (e.g., Apple Health export). Some practices accept emailed PDFs of trend data.
  • Understand false positives and negatives: Irregular rhythm notifications can cause anxiety. Discuss with your doctor when to ignore an alert and when to seek care.

For Clinicians Implementing Wearable Data Integration

  • Start with a targeted patient population: Patients with high AFib burden, rate response issues, or frequent unexplained symptoms benefit most. Avoid overwhelming your practice with data from every patient.
  • Establish clear data review protocols: Who monitors the wearable feed? How often? What threshold triggers an alert? Document these in standard operating procedures.
  • Use a middleware platform: Solutions like Vivify, Biofourmis, or proprietary EHR-integrated tools can ingest smartwatch data and present it alongside device data. This reduces manual data entry and parsing.
  • Educate patients on battery management and data syncing: Many smartwatches require nightly charging, which can disrupt sleep tracking. Recommend an afternoon/early evening charge to maintain overnight recording.

Conclusion

The convergence of pacemaker technology and consumer smartwatches represents a significant step forward in cardiac care. By bridging the gap between intermittent device interrogations and continuous real-world physiology, these wearables offer clinicians a richer dataset for making treatment decisions, improving patient outcomes, and reducing the burden of in-person visits. While challenges remain in data accuracy, privacy, standardization, and reimbursement, the trajectory is clear: integrated monitoring is not a distant future concept but a practical innovation already being pilot-tested in leading cardiac centers. Patients who are well-informed and clinicians who adopt thoughtful implementation strategies can harness the complementary strengths of both technologies to achieve more proactive, personalized, and effective care for the millions living with pacemakers worldwide.